Ochre Bio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Corporate
- Latest Deal Amount
-
$37.5M
- Investors
-
24
Ochre Bio General Information
Description
Developer of a biotechnology platform designed to develop RNA (Ribonucleic Acid) therapies for chronic liver diseases. The company offers human liver data, computational biology, human validation models, and RNA medicine development, enabling biotechnology and pharmaceutical companies to identify therapeutic targets and develop treatments for liver fibrosis and cirrhosis.
Contact Information
Website
www.ochre-bio.comCorporate Office
- Hayakawa Building Oxford Science Park
- Edmund Halley Road
- Oxford OX4 4GB
- England, United Kingdom
Corporate Office
- Hayakawa Building Oxford Science Park
- Edmund Halley Road
- Oxford OX4 4GB
- England, United Kingdom
Ochre Bio Timeline
Ochre Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Corporate | 12-Jun-2024 | $37.5M | Completed | Generating Revenue | ||
| 6. Early Stage VC (Series A2) | 16-Oct-2023 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | 10-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 16-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 18-May-2020 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 18-Mar-2020 | $150K | $150K | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ochre Bio Comparisons
Industry
Financing
Details
Ochre Bio Competitors (11)
One of Ochre Bio’s 11 competitors is Ribocure Pharmaceuticals, a Angel-Backed company based in Mölndal, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ribocure Pharmaceuticals | Angel-Backed | Mölndal, Sweden | ||||
| Alentis Therapeutics | Venture Capital-Backed | Allschwil, Switzerland | ||||
| Resolution Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| Engitix | Venture Capital-Backed | London, United Kingdom | ||||
| Silence Therapeutics | Formerly VC-backed | London, United Kingdom |
Ochre Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ochre Bio Patents
Ochre Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202510779-D0 | Antisense nucleic acid molecules and uses thereof | Pending | 03-Jul-2025 | ||
| GB-202510780-D0 | Antisense nucleic acid molecules and uses thereof | Pending | 03-Jul-2025 | ||
| GB-202510782-D0 | Antisense nucleic acid molecules and uses thereof | Pending | 03-Jul-2025 | ||
| GB-202510784-D0 | Antisense nucleic acid molecules and uses thereof | Pending | 03-Jul-2025 | ||
| GB-202510785-D0 | Antisense nucleic acid molecules and uses thereof | Pending | 03-Jul-2025 |
Ochre Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ochre Bio Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GSK | Corporation | Minority | ||
| CoastCap | Family Office | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Pledge Ventures | Corporate Venture Capital | Minority | ||
| AixThera | Venture Capital | Minority |
Ochre Bio FAQs
-
When was Ochre Bio founded?
Ochre Bio was founded in 2019.
-
Where is Ochre Bio headquartered?
Ochre Bio is headquartered in Oxford, United Kingdom.
-
What is the size of Ochre Bio?
Ochre Bio has 50 total employees.
-
What industry is Ochre Bio in?
Ochre Bio’s primary industry is Drug Discovery.
-
Is Ochre Bio a private or public company?
Ochre Bio is a Private company.
-
What is Ochre Bio’s current revenue?
The current revenue for Ochre Bio is .
-
How much funding has Ochre Bio raised over time?
Ochre Bio has raised $128M.
-
Who are Ochre Bio’s investors?
GSK, CoastCap, Gaingels, Pledge Ventures, and AixThera are 5 of 24 investors who have invested in Ochre Bio.
-
Who are Ochre Bio’s competitors?
Ribocure Pharmaceuticals, Alentis Therapeutics, Resolution Therapeutics, Engitix, and Silence Therapeutics are some of the 11 competitors of Ochre Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
